Select Page

Press Releases

Sign up to get full access to all our latest Press Releases

Rapid Dose Therapeutics Signs Exclusive Manufacturing And Distribution Agreement With Maplex Naturals Inc.

April 13, 2021


BURLINGTON, Ontario – April 13, 2021- Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), is a Canadian Life Science company focused on innovative drug and active ingredient delivery solutions. The flagship product ‘QuickStrip™’ is a thin, orally dissolvable film, infused with an active...

Rapid Dose Therapeutics Closes Purchase and Amalgamation of Consolidated Craft Brands

March 19, 2021


BURLINGTON, Ontario, March 19, 2021 (GLOBE NEWSWIRE) — Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), is a Canadian life sciences company focused on innovative drug and active ingredient delivery solutions. The flagship product ‘QuickStrip™’ is a thin, orally dissolvable film infused with an...

Rapid Dose Therapeutics Signs Production Agreement with OG Laboratories to Produce Cannabis Vape and CBD from Hemp Products

March 10, 2021


BURLINGTON, Ontario, March 10, 2021 (GLOBE NEWSWIRE) — Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE) is a Canadian Life Science company focused on innovative drug and active ingredient delivery solutions. The flagship product ‘QuickStrip™’ is a thin, orally dissolvable film, infused with an active...

Rapid Dose Therapeutics Completes Amalgamation Of Consolidated Craft Brands

March 8, 2021


BURLINGTON, Ontario March 8, 2021 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), is a Canadian life sciences company focused on innovative drug and active ingredient delivery solutions. The flagship product ‘QuickStrip™’ is a thin, orally dissolvable film infused with an active...

Rapid Dose Therapeutics Executes Letter of Intent to Acquire Consolidated Craft Brands

January 11, 2021


BURLINGTON, Ontario January 11, 2021 – Rapid Dose Therapeutics Corp. “RDT” or the “Company”) (CSE: DOSE), a Canadian life sciences company focused on innovative drug and active ingredient delivery solutions, is pleased to announce that it has entered into a binding Letter of Intent “LOI”)...

Rapid Dose Therapeutics Delivers Shipments of Oral Strips to Thrive Cannabis, in Stores Now

December 21, 2020


BURLINGTON, Ontario December 21, 2020 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian life sciences company focused on innovative drug and active ingredient delivery solutions, has worked diligently with its customer, Thrive Cannabis Inc. (“Thrive”), this past year preparing to...

Rapid Dose Therapeutics Closes First Tranche of Non-Brokered Private Placement

December 15, 2020


BURLINGTON, Ontario – December 15, 2020 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian life sciences company focused on innovative drug and active ingredient delivery solutions, is pleased to announce the closing of the first tranche of a Non-Brokered Private...

Rapid Dose Therapeutics Signs Definitive Agreement to Enable Commercial Production of Ultrapure THC™ Distillate Using RDT’s Novel CBD to THC Conversion Technology

November 25, 2020


BURLINGTON, Ontario – November 25, 2020 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian life sciences company focused on innovative drug and active ingredient delivery solutions, is pleased to announce it signed a definitive agreement with ESJ Enterprises, LLC. RDT...

Rapid Dose Therapeutics Corp. Announces Revocation of Cease Trade Order

November 19, 2020


BURLINGTON, Ontario – November 19, 2020 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian life sciences company focused on innovative drug and active ingredient delivery solutions, is pleased to announce it has, as of November 18, 2020, received a Revocation...

Rapid Dose Therapeutics Amends Agreement With Aphria to Produce in Burlington, Ontario Facility

September 29, 2020


BURLINGTON, Ontario – September 29, 2020 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian life sciences company focused on innovative drug and active ingredient delivery solutions, is pleased to announce it has amended the agreement with Aphria Inc. (TSE:APHA, Nasdaq:APHA)...

1 2 3 4 5 6 7